亞洲證券市場報告2015年11月26日- Regeneus Ltd (ASX:RGS)開始犬類癌症疫苗試驗
Regeneus (ASX:RGS),一家臨床階段再生醫藥公司,今天宣布開始其犬類癌症疫苗技術Kvax試驗,結合化學療法治療犬類淋巴瘤。
Cardinal Resources Ltd (ASX:CDV) (TSE:CDV) (OTCMKTS:CRDNF) is a West African gold exploration and development Company that holds interests in tenements within Ghana, West Africa.
The Company is focused on the development of the Namdini Project with a gold Ore Reserve of 5.1Moz (0.4 Moz Proved and 4.7 Moz Probable) and a soon to be completed Feasibility Study.
Exploration programmes are also underway at the Company's Bolgatanga (Northern Ghana) and Subranum (Southern Ghana) Projects.
Cardinal confirms that it is not aware of any new information or data that materially affects the information included in its announcement of the Ore Reserve of 3 April 2019. All material assumptions and technical parameters underpinning this estimate continue to apply and have not materially changed.
Regeneus (ASX:RGS),一家臨床階段再生醫藥公司,今天宣布開始其犬類癌症疫苗技術Kvax試驗,結合化學療法治療犬類淋巴瘤。